Male-female differences in the effects of cannabinoids on sexual behavior and gonadal hormone function

Hormones and Behavior

Volumn 58, Issue 1, 2010, Pages 91-99

  Gorzalka, Boris B ^a   Hill, Matthew N ^b   Chang, Sabrina C H ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Cannabinoid; Cannabis; Endocannabinoid; Gonadotropin; Proceptivity; Receptivity; Sexual behavior; Testosterone; THC

Indexed keywords

CANNABINOID; CANNABINOID RECEPTOR; CANNABIS; ENDOCANNABINOID; GONADOTROPIN; LIGAND; SEX HORMONE; TESTOSTERONE; CENTRAL NERVOUS SYSTEM AGENTS;

ARTICLE; DRUG EFFECT; DRUG USE; FEMALE; GONADOTROPIN RELEASE; HORMONE ACTION; HUMAN; MALE; MOTIVATION; NEUROENDOCRINE SYSTEM; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; SEX DIFFERENCE; SEXUAL AROUSAL; SEXUAL BEHAVIOR; SEXUALITY; ANIMAL; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; SEXUAL DEVELOPMENT;

ANIMALS; CANNABINOIDS; CENTRAL NERVOUS SYSTEM AGENTS; FEMALE; GONADAL HORMONES; HUMANS; MALE; SEX CHARACTERISTICS; SEXUAL BEHAVIOR; SEXUAL BEHAVIOR, ANIMAL;

EID: 77953477890     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2009.08.009     Document Type: Article

References (131)

1. Abel E. Marihuana and sex: a critical survey. Drug Alcohol Depend. 1981, 8:1-22.
2. Ahn K., McKinney M.K., Cravatt B.F. Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem. Rev. 2008, 108:1687-1707.
3. Andersson K.E. Pharmacology of penile erection. Pharmacol. Rev. 2001, 53:417-450.
4. Aversa A., Rossi F., Francomano D., Bruzziches R., Bertone C., Santiemma V., Spera G. Early endothelial dysfunction as a marker of vasculogenic erectile dysfunction in young habitual cannabis users. Int. J. Impot. Res. 2008, 20:566-573.
5. Argiolas A., Melis M.R. Oxytocin-induced penile erection. Role of nitric oxide. Adv. Exp. Med. Biol. 1995, 395:247-254.
6. Argiolas A., Melis M.R. The role of oxytocin and the paraventricular nucleus in the sexual behaviour of male mammals. Physiol. Behav. 2004, 83:309-317.
7. Argiolas A., Melis M.R. Central control of penile erection: role of the paraventricular nucleus of the hypothalamus. Prog. Neurobiol. 2005, 76:1-21.
8. Asch R.H., Smith C.G., Siler-Koder T.M., Pauerstein C.J. Effects of delta-9-tetrahydrocannabinol during the follicular phase of the rhesus monkey. J. Clin. Endocrinol. Metab. 1981, 52:50-55.
9. Bisogno T. Endogenous cannabinoids: structure and metabolism. J. Neuroendocrinol. 2008, 20:1-9.
10. Block R.I., Farinpour R., Schlechte J.A. Effects of chronic marijuana use on testosterone, luteinizing hormone, follicle stimulating hormone, prolactin and cortisol in men and women. Drug Alcohol Depend. 1991, 28:121-128.
11. Brotto L.A., Klein C., Gorzalka B.B. Laboratory-induced hyperventilation differentiates female sexual arousal disorder subtypes. Arch. Sex. Behav. 2009, 38:463-475.
12. Burstein S., Hunter S., Shoupe T. Cannabinoid inhibition of rat luteal cell progesterone synthesis. Res. Commun. Chem. Pathol. Pharmacol. 1979, 24:413-416.
13. Castelli M.P., Piras A.P., Melis T., Succu S., Sanna F., Melis M.R., Collu S., Grazia Ennas M., Diaz G., Mackie K., Argiolas A. Cannabinoid CB1 receptors in the paraventricular nucleus and central control of penile erection: immunocytochemistry, autoradiography and behavioral studies. Neuroscience 2007, 147:197-206.
14. Chopra L.C., Chopra R.N. The use of cannahis drugs in India. Bull. Narc. 1957, 9:4-29.
15. Chopra G.S., Jandu B.S. Psychoclinical effects of long-term marijuana use in 275 Indian chronic users. A comparative assessment of effects in Indian and USA users. Ann. N.Y. Acad. Sci. 1976, 282:95-108.
16. Coddington E., Lewis C., Rose J.D., Moore F.L. Endocannabinoids mediate the effects of acute stress and corticosterone on sex behavior. Endocrinology 2007, 148:493-500.
17. Cohen S. The 94-day cannahis study. Ann. N.Y. Acad. Sci. 1976, 282:211-220.
18. Cohen S. Cannabis and sex: multifaceted paradoxes. J. Psychoactive Drugs. 1982, 14:55-70.
19. Cone E.J., Johnson R.E., Moore J.D., Roache J.D. Acute effects of smoking marijuana on hormones, subjective effects smd performance in male human subjects. Pharmacol. Biochem. Behav. 1986, 24:1749-1754.
20. Sexual pharmacology: drugs that affect sexual functioning 1996, W.W. Norton & Company, New York. T.L. Crenshaw, J.P. Goldberg (Eds.).
21. Cushman P. Plasma testosterone levels in healthy male marijuana smokers. Am. J. Drug Alcohol Abuse 1975, 2:269-275.
22. Cutler MJ., Mackintosh JH. Cannahis and delta-9-tetrahydrocannabinol effects on elements of social behaviour in mice. Neuropharmacology 1984, 23:1091-1097.
23. Dalterio S. Perinatal or adult exposure to cannabinoids alters male reproductive functions in mice. Pharmacol. Biochem. Behav. 1979, 12:143-153.
24. Dalterio S., Bartke A., Burstein S. Cannabinoids inhibit testosterone secretion by mouse testes in vitro. Science 1977, 196:1472-1473.
25. Dalterio S., Bartke A., Roberson C, Watson D., Burstein S. Direct and pituitary-mediated effects of delta9-THC and cannabinol on the testis. Pharmacol. Biochem. Behav. 1977, 8:673-678.
26. Dalterio S., Mayfield D.L., Bartke A. Effects of delta-9-THC on plasma hormone levels in female mice. Subst. Alcohol Actions/Misuse 1983, 4:339-345.
27. Dawley H.H., Winstead D.K., Baxter A.S., Gay J.R. An attitude survey of the effects of marijuana on sexual enjoyment. J. Clin. Psychol. 1979, 35:212-217.
28. DeSanty K.P., Dar M.S. Cannabinoid-induced motor incoordination through the cerebellar CB(1) receptor in mice. Pharmacol. Biochem. Behav. 2001, 69:251-259.
29. Devane W.A., Dysarz F.A., Johnson M.R., Melvin L.S., Howlett A.C. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 1988, 34:605-613.
30. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258:1946-1949.
31. Dhawan K., Sharma A. Restoration of chronic-delta9-THC-induced decline in sexuality in male rats by a novel benzoflavone moiety from Passiflora incarnata Linn. Br. J. Pharmacol. 2003, 138:117-120.
32. Dinh T.P., Carpenter D., Leslie F.M., Freund TF., Katona I., Sensi S.L., Kathuria S., Piomelli D. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:10819-10824.
33. Dixit V.P., Lohiya N.K. Effects of cannabis extracts on the response of accessory sex organs of adult male mice to testosterone Indian. J. Exp. Biol. 1975, 19:98-100.
34. D'Souza D.C, Perry E., MacDougall L., Ammerman Y., Cooper T, Wu Y.T, Braley G., Gueorguieva R., Krystal J.H. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis. Neuropsychopharmacology 2004, 29:1558-1572.
35. Egashira N., Mishima K., Iwasaki K., Fujiwara M. Intracerebral microinjections of delta 9-tetrahydrocannabinol: search for the impairment of spatial memory in the eight-arm radial maze in rats. Brain Res. 2002, 952:239-245.
36. Ferrari F., Ottani A., Giuhani D. Inhibitory effects of the cannabinoid agonist HU 210 on rat sexual behaviour. Physiol. Behav. 2000, 69:547-554.
37. Ford W.R., Honan S.A., White R., Hiley C.R. Evidence of a novel site mediating anandamide-induced negative inotropic and coronary vasodilatator responses in rat isolated hearts. Br. J. Pharmacol. 2002, 135:1191-1198.
38. Frischknecht H., Sieber B., Waser P. Effects of multiple, chronic and early hashish exposure on mating behavior, nest-building and gestation in mice. Comp. Biochem. Physiol., C Toxicol. Pharmacol. 1982, 72:363-368.
39. Fujimoto G., Morrill G., O'Connell M., Kostellow A., Retura G. Effects of cannabinoids given orally and reduced appetite on the male rat reproductive system. Pharmacology 1982, 24:303-313.
40. Gammon C.M., Freeman G.M., Xie W., Petersen S.L., Wetsel W.C. Regulation of gonadotropin-releasing hormone secretion by cannabinoids. Endocrinology 2005, 146:4491-4499.
41. Gawin F.H. Pharmacologic enhancement of the erotic: implications of an expanded definition of aphrodisiacs. J. Sex Res. 1978, 14:107-117.
42. Ghasemi M., Sadeghipour H., Mani A.R., Tavakoli S., Hajrasouliha A.R., Ebrahimi F., Dehpour A.R. Effect of anandamide on nonadrenergic noncholinergic-mediated relaxation of rat corpus cavernosum. Eur. J. Pharmacol. 2006, 544:138-145.
43. Ghosh S., Chatterjee T., Ghosh J. Antiandrogenic effect of delta-9-tetrahydrocannabinol in adult castrated rats. J. Reprod. Fertil. 1981, 62:513-517.
44. Giraldi A., Marson L., Nappi R., Pfaus J., Traish A.M., Vardi Y., Goldstein I. Physiology of female sexual function: animal models. J. Sex Med. 2004, 1:237-253.
45. Giuliano F., Rampin O. Central neural regulation of penile erection. Neurosci. Biobehav. Rev. 2000, 24:517-533.
46. Gordon J.H., Bromley B.L., Gorski R.A., Zimmermann E. Delta9-tetrahydrocannahinol enhancement of lordosis behavior in estrogen treated female rats. Pharmacol. Biochem. Behav. 1978, 8:603-608.
47. Gorzalka B.B., Mendelson S.D., Watson N.V. Serotonin receptor subtypes and sexual behavior. Ann. N.Y. Acad. Sci. 1990, 600:435-444.
48. Gorzalka B.B., Hanson L.A., Brotto L.A. Chronic stress effects on sexual behavior in male and female rats: mediation by 5-HT2A receptors. Pharmacol. Biochem. Behav. 1998, 61:405-412.
49. Gorzalka B.B., Hanson L.A., Hong J.J. Ketanserin attenuates the behavioural effects of corticosterone: implications for 5-HT(2A) receptor regulation. Eur. J. Pharmacol. 2001, 428:235-240.
50. Gorzalka B.B., Hill M.N., Hillard C.J. Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders. Neurosci. Biobehav. Rev. 2008, 32:1152-1160.
51. Gorzalka B.B., Morrish A.C., Hill M.N. Endocannabinoid modulation of male rat sexual behavior. Psychopharmacology 2008, 198:479-486.
52. Gratzke C., Christ G.J., Stief C.G., Andersson K.E., Hedlund P. Localization and function of cannabinoid receptors in the corpus cavernosum: basis for modulation of nitric oxide synthase nerve activity. Eur. Urol. 2009, 57:342-349.
53. Halikas J., Weller R., Morse C. Effects of regular marijuana use on sexual performance. J. Psychoact. Drugs 1982, 14:59-70.
54. Haring M., Marsicano G., Lutz B., Monory K. Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice. Neuroscience 2007, 146:1212-1219.
55. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 1991, 11:563-583.
56. Hill M.N., McLaughlin R.J., Morrish A.C., Viau V., Floresco S.B., Hillard C.J., Gorzalka B.B. Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis. Int. J. Neuropsychopharmacol. 2009, 34:2733-2745.
57. Hill M.N., Sun J.C., Tse M.T., Gorzalka B.B. Altered responsiveness of serotonin receptor subtypes following long-term cannabinoid treatment. Int. J. Neuropsychopharmacol. 2006, 9:277-286.
58. Ho B.T., Fritchie G.E., Kralik P.M., Englert L.F, Mclsaac W.M., Idanpaan-Heikkila J. Distribution of tritiated l-delta-9-tetrahydrocannahinol in rat tissues after inhalation. J. Pharm. Pharmacol. 1970, 22:538-539.
59. Hull E.M., Muschamp J.W., Sato S. Dopamine and serotonin: influences on male sexual behavior. Physiol. Behav. 2004, 83:291-307.
60. Indian Hemp Drugs Commission, 1894. Government Printing Office, London.
61. Isbell H., Gorodetzsky C.W, Jasinski D., Claussen U., von Spulak F., Korte F. Effects of (-) delta-9-tetrahydrocannabinol in man. Psychopharmacology 1967, 11:184-188.
62. Jackson A.L., Murphy L.L. Role of the hypothalamic-pituitary-adrenal axis in the suppression of luteinizing hormone release by delta-9-tetrahydrocannabinol. Neuroendocrinology 1997, 65:446-452.
63. Jakubovic A., McGeer E., McGeer P. Effects of cannabinoids on testosterone and protein synthesis in rat testis Leydig cells in vitro. Mol. Cell. Endocrinol. 1979, 15:41-50.
64. Jarvik M., Brecher E. Drugs and sex: inhibition and enhancement. Handbook of sexology 1977, 1095-1106. Elsevier/North Holland Biomedical Press, Amsterdam. J. Money, H. Musaph (Eds.).
65. Johnson S.D., Phelps D.L., Cottler L.B. The association of sexual dysfunction and substance use among a community epidemiological sample. Arch. Sex. Behav. 2004, 33:55-63.
66. Koff W. Marijuana and sexual activity. J. Sex Res. 1974, 10:194-204.
67. Kolansky H., Moore W.T. Toxic effects of chronic marihuana use. JAMA 1972, 222:35-41.
68. Kolodny R.C., Masters W.H., Kolodner R.M., Toro G. Depression of plasma testosterone levels after chronic intensive marihuana use. N. Engl. J. Med. 1974, 290:872-874.
69. Kolodny R.C, Toro G., Masters W.H. N. Engl. J. Med. 1975, 292:868.
70. Kolodny R.C., Lessin P., Toro G., Masters W.H., Cohen S. Depression of plasma testosterone with acute marihuana administration. The pharmacology of marihuana 1976, 217-225. Raven Press, New York. M.C. Braude, S. Szara (Eds.).
71. Kolodny, R.C, Bauman, J. E., Biggs, M.A., Webster, S.K., Dornbush, R.L., 1977. Endocrine and sexual effects of female chronic marihuana use. Paper presented at the Annual Meeting of the International Academy of Sex Research, Bloomington, IN.
72. Kolodny R.C., Masters W.H., Johnson V. Textbook of sexual medicine 1979, Little Brown, Boston.
73. Kostellow A.B., Ziegler D., Kunar J., Fujimoto G.I., Morrill G.A. Effect of cannabinoids on estrous cycle, ovulation and reproductive capacity of female A/J mice. Pharmacology 1980, 21:68-75.
74. Kumar M., Chen C. Effect of an acute dose of delta9-THC on hypothalamic luteinizing hormone releasing hormone and met-enkephalin content and serum levels of testosterone and corticosterone in rats. Subst. Alcohol Actions/Misuse 1983, 4:37-43.
75. Lewis B. The sexual power of marijuana 1970, Peter H. Wyden, Inc, New York.
76. Lichtman A.H., Cook S.A., Martin B.R. Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement. J. Pharmacol. Exp. Ther. 1996, 276:585-593.
77. List A., Nazar B., Nyquist S., Harclerode J. The effects of delta9-tetrahydrocannabinol and cannabidiol on the metabolism of gonadal steroids in the rat. Drug Metab. Dispos. 1977, 5:268-272.
78. López H.H., Webb S.A., Nash S. Cannabinoid receptor antagonism increases female sexual motivation. Pharmacol. Biochem. Behav. 2009, 92:17-24.
79. Mackie K. Signaling via CNS cannabinoid receptors. Mol. Cell. Endocrinol. 2008, 286:S60-65.
80. Mani S., Mitchell A., O'Malley B. Progesterone receptor and dopamine receptors are required in delta9-tetrahydrocannabinol modulation of sexual receptivity in female rats. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:1249-1254.
81. Manzanares J., Corchero J., Funtes J.A. Opioid and cannabinoid receptormediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of delta(9)-tetrahydrocannabinol in rats. Brain Res. 1999, 839:173-179.
82. Marks B.H. Delta-1-THC and luteinizing hormone secretion. Progress in brain research-drug effects on neuroendocrine regulation 1973, 33-38. Eisevier, Amsterdam. E. Zimmerman, W.H. Gispen, B.H. Marks, D. de Wied (Eds.).
83. Martinez-Gonzalez D., Bonilla-Jaime H., Morales-Otal A., Henriksen S., Velazquez-Moctezuma J., Prospero-Garcia O. Oleamide and anandamide effects on food intake and sexual behavior of rats. Neurosci. Lett. 2004, 364:1-6.
84. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C, Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346:561-564.
85. Matyas F., Urban G.M., Watanabe M., Mackie K., Zimmer A., Freund T.F., Katona I. Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. Neuropharmacology 2008, 54:95-107.
86. McKay A. Sexuality and substance use: the impace of tobacco, alcohol, and selected recreational drugs on sexual function. Can. J. Hum. Sex. 2005, 14:41-56.
87. McKenna K.E. Some proposals regarding the organization of the central nervous system control of penile erection. Neurosci. Biobehav. Rev. 2000, 24:535-540.
88. McLaughlin R.J., Hill M.N., Morrish A.C., Gorzalka B.B. Local enhancement of cannabinoid CB1 receptor signalling in the dorsal hippocampus elicits an antidepressant-like effect. Behav. Pharmacol. 2007, 18:431-438.
89. Melges F.T., Tinklenberg J.R., Hollister L.E., Gillespie H.K Marihuana and the temporal span of awareness. Arch. Gen. Psychiatry 1971, 24:564-567.
90. Melis M.R., Argiolas A. Central oxytocinergic neurotransmission: a drug target for the therapy of psychogenic erectile dysfunction. Curr. Drug Targets 2003, 4:55-66.
91. Melis M.R., Succu S., Mascia M.S., Argiolas A. Antagonism of cannabinoid CB1 receptors in the paraventricular nucleus of male rats induces penile erection. Neurosci. Lett. 2004, 359:17-20.
92. Melis M.R., Succu S., Mascia M.S., Sanna F., Melis T., Castelli M.P., Argiolas A. The cannabinoid receptor antagonist SR-141716A induces penile erection in male rats: involvement of paraventricular glutamic acid and nitric oxide. Neuropharmacology 2006, 50:219-228.
93. Mendelson J., Kuehnle J., Ellingboe J., Babor T. Plasma testosterone levels before, during and after chronic marihuana smoking. N. Engl. J. Med. 1974, 291:1051-1055.
94. Mendelson J.H., Ellingboe J., Kuehnle J.C., Mello N.K. Effects of chronic marihuana use on integrated plasma testosterone and luteinizing hormone levels. J. Pharmacol. Exp. Ther. 1978, 207:611-617.
95. Merari A., Barak A., Plaves M. Effects of l(2)-tetrahydrocannabinol on copulation in the male rat. Psychopharmacologia 1973, 28:243-246.
96. Motofei I.G., Rowland D.L. The physiological basis of human sexual arousal: Neuroendocrine sexual asymmetry. Int. J. Androl. 2005, 28:78-87.
97. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365:61-65.
98. Murphy L.L., Steger R.W., Smith M.S., Bartke A. Effects of delta-9-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combinations, on luteinizing hormone and prolactin release and on hypothalamic neurotransmitters in the male rat. Neuroendocrinology 1990, 52:316-321.
99. Murphy L., Gher J., Steger R., Bartke A. Effects of delta9-tetrahydrocannabinol on copulatory behavior and neuroendocrine responses of male rats to female conspecifics. Pharmacol. Biochem. Behav. 1994, 48:1011-1017.
100. Marihuana: A signal of misunderstanding 1972, National Commission on Marihuana and Drug Abuse, Government Printing Office, Washington, DC.
101. Nir I., Ayalon D., Tsafriri A., Cordova T, Lindner H.R. Suppression of the cyclic surge of luteinizing hormone secretion and of ovulation in the rat by delta-1-tetrahydrocannabinol. Nature 1973, 243:470-471.
102. Oz M. Receptor-independent effects of endocannabinoids on ion channels. Curr. Pharm. Des. 2006, 12:227-239.
103. Patel S., Hillard C.J. Cannabinoid CB(1) receptor agonists produce cerebellar dysfunction in mice. J. Pharmacol. Exp. Ther. 2001, 297:629-637.
104. Pertwee R.G. The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids. AAPS J. 2005, 7:554-625.
105. Pertwee R.G. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Br. J. Pharmacol. 2008, 153:199-215.
106. Purohit V., Ahluwahha B.S., Vigersky R.A. Marihuana inhibits dihydrotestosterone binding to the androgen receptor. Endocrinology 1980, 107:848-850.
107. Reese C.R. Neurophysiological studies of cannabis in human subjects. J. Subst. Use Abuse 1977, 4:118-127.
108. Rosencrantz H., Esber H. Cannabinoid-induced hormone changes in monkeys and rats. J. Toxicol. Environ. Health 1980, 6:297-313.
109. Rubino T., Guidali C., Vigano D., Realini N., Valenti M., Massi P., Parolaro D. CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour. Neuropharmacology 2008, 54:151-160.
110. Sabatier N., Leng G. Presynaptic actions of endocannabinoids mediate alpha-MSH-induced inhibition of oxytocin cells. Am. J. Physiol., Regul. Integr. Comp. Physiol. 2006, 290:R577-R584.
111. Sassenrath E.N., Chapman L.F. Tetrahydrocannabinol-induced manifestations of the ″ marihuana syndrome″ in group-living macaques. Fed. Proc. 1975, 34:1666-1670.
112. Schaefer C., Gunn C., Duhowski K. Normal plasma testosterone concentrations after marihuana smoking. N. Engl. J. Med. 1975, 292:867-868.
113. Scher J. The marijuana habit. JAMA 1970, 214:1120.
114. Schlicker E., Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Neurosci. 2001, 22:565-572.
115. Shrenker P., Bartke A. Suppression of male copulatory behavior by delta9-THC is not dependent on changes in plasma testosterone or hypothalamic dopamine or serotonin content. Pharmacol. Biochem. Behav. 1985, 22:415-420.
116. Smith C.G., Moore C.E., Besch N.F., Besch P.K. The effect of marihuana delta-9-tetrahydrocannabinol on the secretion of sex hormones in the mature male rhesus monkey. Clin. Chem. 1976, 22:1184-1187.
117. Smith C.G., Besch N.F, Smith R.G., Besch P.K. Effect of tetrahydrocannabinol on the hypothalamic-pituitary axis in the ovariectomized rhesus monkey. Fertil. Steril. 1979, 31:335-339.
118. Succu S., Mascia M.S., Sanna F., Melis T., Argiolas A., Melis M.R. The cannabinoid CB1 receptor antagonist SR 141716A induces penile erection by increasing extra-cellular glutamic acid in the paraventricular nucleus of male rats. Behav. Brain Res. 2006, 169:274-281.
119. Sugiura T, Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., Yamashita A., Waku K. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 1995, 215:89-97.
120. Symons A.M., Teale J.D., Marks V. Effect of delta-9-tetrahydrocannabinol on the hypothalamic-pituitary-gonadal system in the maturing male rat. Endocrinology 1976, 68:43-44.
121. Tart C.T. Marijuana intoxication common experiences. Nature 1970, 226:701-704.
122. Tsou K., Brown S., Sanudo-Pena M.C, Mackie K., Walker J.M. Immunohistochemical distribution of cannabinoid CBl receptors in the rat central nervous system. Neuroscience 1998, 83:393-411.
123. Turley W., Floody O. Delta9-tetrahydrocannabinol stimulates receptive and proceptive sexual behaviors in female hamsters. Pharmacol. Biochem. Behav. 1981, 14:745-747.
124. Tyrey L. Delta-9-tetrahydrocannabinol suppression of episodic luteinizing hormone secretion in the ovariectomized rat. Endocrinology 1978, 102:1808-1814.
125. Uyeno E. Effects of delta9-tetrahydrocannahinol & 2,5-dimethoxy-4-methylamphetamine on rat sexual dominance behavior. Proc. West. Pharmacol. Soc. 1976, 19:169-372.
126. van Anders S.M., Chernick A.B., Chernick B.A., Hampson E., Fisher W.A. Preliminary clinical experience with androgen administration for pre- and postmenopausal women with hypoactive sexual desire. J. Sex Marital Ther. 2005, 31:173-185.
127. Vettor R., Pagotto U., Pagano C., Pasquali R. Here, there and everywhere: the endocannabinoid system. J. Neuroendocrinol. 2008, 20:s4-6.
128. Vural I.M., Ozturk G.S., Sarioglu Y. Functional characterization of nonadrenergic noncholinergic neurotransmitter release via endocannabinoids: an in vitro study in rabbit corpus cavernosum. J. Sex Med. 2009, 6:717-729.
129. Wall M.E., Brine D.R., Perez-Reyes M. Technical reports from Research Triangle to National Institute of Drug Abuse 1978, National Institute on Drug Abuse, Rockville, MD.
130. Weller R.A., Halikas J.A. Marijuana use and sexual behavior. J. Sex Res. 1978, 20:186-193.
131. Wenger T., Ledent C., Csernus V., Gerendai I. The central cannabinoid receptor inactivation suppresses endocrine reproductive functions. Biochem. Biophys. Res. Commun. 2001, 284:363-368.